| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |